rapidli
advanc
possibl
biotechnolog
outstrip
adapt
capac
current
legal
ethic
institut
vigor
debat
arisen
consid
boundari
appropri
use
technolog
particularli
appli
human
articl
examin
ethic
concern
surround
develop
market
particular
form
human
genet
engin
heterozygot
fitter
homozygot
condit
known
heterozyg
advantag
begin
present
gener
model
condit
illumin
applic
sicklecel
anemia
next
propos
typolog
relat
market
current
function
avail
product
servic
other
wide
view
immin
suggest
manner
pervers
incent
may
aris
firm
market
genet
intervent
circumst
heterozyg
advantag
possibl
final
propos
misalign
incent
social
welfar
arisen
illconceiv
market
intervent
market
capabl
achiev
effici
outcom
lack
market
intervent
market
fail
offer
specif
legal
regulatori
approach
reform
bolster
gregor
recent
work
hered
pea
promis
new
credibl
scientif
notion
hereditari
determin
possibl
soften
advanc
age
franci
galton
deliv
major
address
newli
form
sociolog
societi
brook
talk
eugen
definit
scope
aim
somewhat
inclus
previou
work
class
individu
whose
excel
reproduc
futur
benefit
societi
gave
birth
modern
social
philosophi
eugen
gillham
advoc
improv
human
genet
qualiti
mean
social
intervent
gave
rise
nazi
polici
racial
hygien
mass
extermin
atroc
caus
much
scientif
commun
distanc
eugen
mani
nation
includ
unit
state
canada
sweden
continu
activ
eugen
program
involuntari
steril
marriag
law
immigr
restrict
recent
dramat
advanc
biotechnolog
industri
return
question
regard
genet
intervent
forefront
ethic
scientif
discours
viewpoint
rang
celebr
promis
biolog
enhanc
naam
embrac
unregul
biotechnolog
part
libertarian
polit
agenda
bailey
cautiou
danger
may
coincid
potenti
benefit
technolog
garreau
suggest
biotechnolog
social
destabil
warn
legal
regulatori
step
necessari
reign
risk
mehlman
go
far
argu
moral
oblig
employ
eugen
mean
improv
qualiti
life
prevent
needless
suffer
futur
gener
buchanan
et
al
glad
rosen
savulescu
savulescu
inde
galton
set
stage
argument
immedi
follow
famou
statement
compar
advantag
man
natur
cite
assert
imper
lie
within
power
becom
duti
work
direct
brook
p
rather
join
gener
debat
consid
boundari
appropri
use
biotechnolog
particularli
appli
human
articl
examin
duti
work
direct
genet
intervent
cost
benefit
misalign
advantag
engin
intervent
consid
give
rise
increas
risk
descend
benefit
time
decis
relat
research
associ
market
develop
may
offer
differenti
advantag
econom
polit
power
insur
market
perpetu
biotechnolog
firm
make
decis
articl
examin
novel
ethic
concern
surround
develop
market
particular
form
human
genet
engin
heterozygot
individu
carri
differ
version
particular
gene
two
correspond
chromosom
fitter
homozygot
individu
carri
two
ident
copi
particular
gene
two
correspond
chromosom
condit
known
heterozyg
advantag
begin
gener
model
condit
illumin
applic
sicklecel
anemia
diseas
perpetu
condit
outlin
market
heterozyg
advantag
technolog
exist
well
technolog
wide
view
immin
next
consid
number
ethic
concern
present
combin
heterozyg
advantag
possibl
biotechnolog
intervent
suggest
manner
pervers
incent
may
aris
firm
market
genet
intervent
circumst
heterozyg
advantag
possibl
final
discuss
market
imperfect
sourc
ethic
dilemma
offer
modest
propos
address
shortcom
human
genom
made
pair
chromosom
one
set
mother
one
set
father
mani
human
genet
characterist
depend
whether
particular
gene
allel
given
locat
chromosom
locu
ident
differ
allel
correspond
locu
pair
chromosom
gene
ident
individu
homozyg
respect
gene
differ
individu
heterozyg
respect
gene
consequ
pair
genotyp
dire
case
individu
homozyg
respect
sicklecel
hemoglobin
allel
result
suffer
lethal
condit
sicklecel
anemia
ordinari
circumst
individu
homozyg
normal
allel
rel
fit
abnorm
homozygot
least
fit
heterozygot
would
expect
diseas
like
sicklecel
anemia
would
rel
quickli
disappear
due
natur
select
sicklecel
anemia
disappear
substanti
evid
heterozyg
individu
one
normal
allel
one
sicklecel
allel
substanti
advantag
homozyg
normal
individu
resist
malari
infect
singl
sicklecel
allel
benign
individu
malari
pathogen
attack
red
blood
cell
sicklecel
allel
shut
infect
make
possibl
immun
system
destroy
pathogen
offer
individu
high
level
immun
malaria
individu
homozyg
sicklecel
allel
suffer
sicklecel
anemia
individu
homozyg
normal
allel
risk
infect
malaria
result
heterozygot
enjoy
distinct
fit
advantag
thu
rel
preval
popul
fisher
fisher
haldan
wright
first
glanc
may
seem
like
good
news
mate
two
heterozyg
individu
result
chanc
child
gregori
todd
jone
reidar
hagtvedt
homozyg
sicklecel
allel
chanc
child
homozyg
normal
allel
suscept
malaria
chanc
heterozyg
child
particularli
area
subject
outbreak
malaria
three
genotyp
persist
stabl
polymorph
relationship
sinc
outcom
limit
sicklecel
anemia
turn
gener
model
gener
model
polymorph
due
heterozyg
advantag
order
estim
rel
fit
homozygot
compar
heterozygot
first
estim
expect
frequenc
genotyp
let
follow
notat
repres
two
type
homozygot
heterozygot
let
n
denot
normal
version
allel
variant
allel
reduct
fit
normal
anan
homozygot
suffer
rel
heterozygot
reduct
fit
variant
asa
homozygot
assum
zero
one
fit
heterozygot
normal
one
let
p
repres
frequenc
n
popul
q
repres
frequenc
popul
p
q
sum
uniti
p
q
direct
relationship
frequenc
gene
frequenc
genotyp
popul
repres
genotyp
frequenc
f
anan
f
ana
f
asa
respect
preval
n
allel
exampl
half
heterozygot
gene
homozygot
normal
gene
type
n
assum
random
mate
select
pressur
expect
genotyp
frequenc
offspr
gener
calcul
genotyp
frequenc
parent
gener
use
hardyweinberg
equilibrium
model
name
british
mathematician
godfrey
harold
hardi
hardi
german
physician
wilhelm
weinberg
weinberg
independ
formul
principl
let
prime
denot
frequenc
offspr
gener
heterozygot
ana
aris
follow
cross
parent
genotyp
ananasa
asasanan
ananana
anasanan
anasana
anasasa
asasana
number
parenthes
proport
offspr
heterozyg
genotyp
assum
probabl
mate
genotyp
random
probabl
two
normal
homozygot
mate
f
anan
henc
offspr
popul
frequenc
heterozygot
type
simplifi
f
ana
anan
ana
asa
ana
similarli
anan
p
asa
q
howev
result
assum
equal
fit
defin
characterist
heterozyg
advantag
mix
two
differ
allel
fit
either
homozygot
select
assum
genotyp
frequenc
must
adjust
use
paramet
find
follow
genotyp
ratio
adult
offspr
gener
p
q
sicklecel
anemia
studi
conduct
nigeria
bodmer
cavallisforza
found
follow
genotyp
frequenc
f
anan
f
ana
f
asa
particular
import
concern
articl
empir
distribut
use
calcul
estim
rel
reduct
fit
two
homozygot
begin
frequenc
n
allel
p
frequenc
allel
q
comput
hardyweinberg
equilibrium
model
may
use
estim
frequenc
differ
genotyp
select
pressur
worth
note
empir
observ
reveal
fewer
homozygot
type
consequ
heterozygot
would
expect
hardyweinberg
equilibrium
take
ratio
empir
expect
frequenc
normal
heterozygot
fit
word
assum
random
remov
effect
estim
nigerian
sampl
indic
sicklecel
homozygot
live
reproduc
due
deleteri
effect
genet
defect
normal
homozygot
without
protect
one
sicklecel
allel
die
reproduc
due
malaria
far
demonstr
heterozygot
may
rel
advantag
question
remain
polymorph
relationship
genotyp
could
reach
equilibrium
popul
sicklecel
homozygot
continu
exist
popul
given
signific
neg
pressur
natur
select
order
address
question
begin
calcul
gene
frequenc
equilibrium
assum
equilibrium
frequenc
p
p
q
center
around
respect
way
sampl
mean
center
around
l
know
ratio
genotyp
frequenc
p
defin
p
sum
ie
r
p
adult
genotyp
frequenc
equilibrium
number
divid
r
equilibrium
gene
frequenc
may
calcul
genotyp
frequenc
like
p
q
sum
uniti
p
therefor
need
solv
one
say
p
f
anan
f
ana
substitut
multipli
p
divid
p
insert
p
collect
term
follow
either
p
p
must
true
p
sicklecel
allel
die
heterozyg
advantag
longer
appli
therefor
conclud
p
p
sinc
preval
gene
adult
popul
depend
rel
fit
reduct
use
equilibrium
condit
assess
affect
chang
fit
includ
intervent
concern
articl
exampl
malaria
parasit
develop
increas
resist
avail
medic
increas
sicklecel
mutat
spread
convers
malaria
cure
sicklecel
allel
becom
extinct
hand
sicklecel
homozygot
becom
like
surviv
reproduc
eg
modern
medicin
decreas
preval
sicklecel
allel
increas
provid
select
pressur
malaria
remain
constant
final
sicklecel
diseas
becom
even
lethal
affect
individu
becom
like
die
without
reproduc
mutant
allel
becom
less
preval
sicklecel
anemia
genet
defect
perpetu
select
mechan
character
heterozyg
advantag
carrier
allel
cystic
fibrosi
recess
hereditari
diseas
lung
sweat
gland
digest
system
much
less
like
die
diseas
predominantli
cholera
involv
loss
bodili
fluid
due
diarrhea
meindl
evid
taysach
diseas
genet
disord
common
jewish
popul
offer
increas
resist
tuberculosi
koeslag
et
al
cf
spyropoulo
et
al
arm
gener
model
heterozyg
advantag
understand
condit
maintain
polymorph
popul
otherwis
maladapt
gene
turn
consider
possibl
market
respons
result
demand
genet
intervent
genet
intervent
respons
heterozyg
advantag
could
conceiv
occur
number
differ
way
would
associ
market
case
howev
clear
technolog
interven
genet
consum
demand
intervent
must
coexist
order
expect
produc
offer
suppli
section
first
consid
class
technolog
genet
intervent
exist
time
other
wide
view
immin
outlin
group
consum
distinguish
vari
level
demand
differ
class
technolog
follow
distinguish
sever
layer
technolog
roughli
ascend
order
regard
graviti
perman
rank
also
hold
reason
well
regard
intens
ethic
concern
associ
particular
technolog
although
perfectli
due
fact
ascend
list
like
present
technolog
current
avail
genet
test
technolog
exist
time
eg
geever
et
al
wu
et
al
rel
econom
sprinkl
et
al
due
noninvas
natur
test
often
thought
technic
genet
intervent
howev
genet
test
make
possibl
rel
passiv
form
genet
intervent
select
abort
embryo
select
enhanc
blank
merrick
mehlman
clearli
genet
test
result
use
discourag
prospect
parent
children
fact
prohibit
children
thought
way
ultim
genet
intervent
laden
seriou
ethic
concern
paren
asch
often
possibl
mimic
effect
gene
pharmaceut
specif
suppli
protein
medic
oppos
let
gene
produc
molecul
eg
mccombi
mccombi
sens
everi
time
fda
approv
protein
treat
diseas
level
genet
manipul
occur
ridley
case
malaria
exist
sever
pharmaceut
treatment
yet
none
use
sickl
effect
mechan
fight
malari
pathogen
individu
heterozyg
sicklecel
allel
altern
may
possibl
exchang
blood
add
artifici
red
blood
cell
one
sicklecel
gene
convey
malari
resist
case
treatment
would
probabl
last
limit
time
would
face
ethic
difficulti
exist
malaria
treatment
signific
side
effect
decad
possibl
directli
alter
specif
gene
human
eg
chang
et
al
et
al
theoret
possibl
therefor
modifi
genet
structur
specif
cell
bodi
captur
advantag
offer
heterogen
sicklecel
allel
benefit
would
short
live
modifi
cell
like
cell
would
eventu
die
new
unmodifi
cell
take
place
advanc
one
addit
level
hierarchi
intervent
offer
perman
effect
least
individu
seek
intervent
anderson
luo
saltzman
stemcel
creat
somat
cell
reengin
produc
genet
alter
somat
cell
process
often
accomplish
marrow
transplant
exampl
walter
et
al
effect
intervent
would
perman
patient
howev
sequestr
germ
line
earli
human
develop
intervent
would
affect
descend
individu
undergo
stemcel
gene
intervent
walter
et
al
final
fundament
germ
line
alter
genet
chang
may
perman
descend
person
genet
modifi
eg
lassnig
et
al
ku
et
al
due
reciproc
effect
germ
line
sequestr
howev
modif
would
impact
somat
cell
individu
receiv
treatment
anderson
given
stark
separ
decis
make
consequ
due
fact
germ
line
intervent
would
effect
genet
materi
futur
descend
includ
germ
line
somat
cell
prospect
intervent
rais
understand
grave
concern
respons
unborn
gener
agiu
busuttil
multipl
level
genet
intervent
character
technic
sophist
rel
perman
one
imagin
sever
group
consum
would
gener
differ
characterist
demand
market
investig
consum
group
structur
around
effect
malaria
preval
sicklecel
allel
illustr
purpos
observ
easili
gener
instanc
heterozyg
advantag
tourist
often
seek
prevent
measur
plan
visit
part
world
malaria
parasit
common
cdc
http
wwwcdcgovtravel
develop
part
world
sicklecel
gene
rare
ridley
visitor
resourc
invest
intervent
would
also
like
natur
resist
malaria
provid
least
preval
sicklecel
gene
group
howev
one
could
envis
consum
would
will
pay
genet
test
determin
natur
resist
particularli
test
econom
compar
intervent
option
less
expens
pharmaceut
intervent
could
develop
reduc
side
effect
would
especi
robust
demand
intervent
type
certainli
possibl
visitor
might
will
alter
somat
cell
eg
method
similar
blood
dope
use
athlet
increas
perform
degre
risk
associ
discomfort
purpos
shortterm
visit
may
render
market
unrealist
similarli
stemcel
intervent
would
like
drastic
appropri
meet
particular
need
final
germ
line
intervent
would
offer
impact
visitor
offspr
would
relev
sum
would
expect
visitor
demand
test
possibl
pharmaceut
intervent
like
noth
expatri
also
often
popul
littl
sicklecel
genet
frequenc
hamper
addit
complic
current
treatment
malaria
prevent
taken
continu
long
period
time
mccombi
henc
would
expect
seek
option
visitor
possibl
addit
longterm
treatment
may
base
stemcel
alter
provid
wish
resid
perman
countri
signific
risk
contract
malaria
may
also
wish
alter
germ
line
provid
protect
children
local
popul
malaria
burden
countri
typic
poorer
tourist
visit
gallup
sach
higher
frequenc
sicklecel
gene
henc
higher
level
natur
resist
parasit
ridley
therefor
demand
might
expect
categori
consum
would
differ
demand
visitor
expatri
differ
complic
need
distinguish
three
local
genotyp
local
heterozygot
easiest
assess
alreadi
natur
resist
malaria
sicklecel
gene
confer
may
interest
genet
test
prospect
mate
offspr
would
rational
demand
pharmaceut
product
mimic
sicklecel
genet
effect
would
reason
interest
drastic
form
genet
intervent
except
possibl
offspr
heterozygot
local
homozygot
fall
normal
sicklecel
categori
normal
allel
suffer
sicklecel
anemia
vulner
malaria
sicklecel
homozygot
like
die
sicklecel
relat
diseas
prior
reproduc
ridley
expect
would
interest
genet
test
otherwis
interest
coincid
unless
daunt
cost
differenti
sicklecel
homozygot
would
interest
somat
genet
therapi
stemcel
intervent
avail
sinc
latter
would
requir
singl
intervent
compar
intermin
treatment
howev
assum
test
result
use
screen
potenti
mate
assum
confid
odd
mate
normal
homozygot
may
well
prefer
stemcel
level
intervent
germ
line
intervent
sicklecel
homozygot
mate
normal
homozygot
produc
heterozygot
inher
advantag
unlik
pharmaceut
intervent
would
offer
advantag
sinc
sicklecel
homozygot
would
alreadi
rel
immun
toward
malaria
treat
sicklecel
anemia
requir
alter
red
blood
cell
normal
homozygot
hand
would
interest
ident
expatri
although
would
averag
tend
fewer
resourc
gallup
sach
reli
upon
typolog
market
genet
intervent
understood
term
classif
technolog
consum
group
turn
consider
ethic
question
aris
circumst
heterozyg
advantag
possibl
prospect
market
outlin
rais
numer
ethic
question
us
today
loom
horizon
gener
technolog
genet
intervent
present
concern
regard
genet
discrimin
genet
determin
eugen
specif
question
numer
catalog
avail
test
intervent
creat
new
duti
associ
liabil
physician
medic
care
provid
insur
compani
allow
respond
knowledg
relat
genet
blueprint
law
prohibit
genet
discrimin
necessari
effect
genet
profil
kept
confidenti
right
privaci
overridden
right
famili
member
particularli
descend
given
recognit
right
individu
right
choos
know
genet
makeup
right
refus
intervent
purpos
howev
limit
consider
two
specif
concern
owe
salienc
possibl
heterozyg
advantag
intergener
issu
involv
increas
risk
descend
seek
current
benefit
genet
intervent
possibl
pervers
incent
research
market
develop
maladapt
polymorph
support
heterozyg
advantag
ignor
moment
signific
risk
unintend
consequ
descend
individu
undergo
germ
line
intervent
consid
remain
risk
inher
popul
affect
heterozyg
advantag
sake
discuss
imagin
homozyg
individu
abl
ongo
somat
treatment
stemcel
modif
alter
genet
blueprint
fall
victim
sicklecel
anemia
homozyg
sicklecel
case
malaria
homozyg
normal
case
imagin
individu
abl
alter
germ
line
heterozyg
gene
pass
along
futur
gener
final
suppos
individu
abl
identifi
heterozyg
mate
either
due
widespread
use
intervent
popul
test
individu
mate
enjoy
freedom
sicklecel
diseas
immun
malaria
due
intervent
point
children
fortun
offspr
chanc
enjoy
heterozyg
condit
face
chanc
born
homozyg
normal
suscept
malaria
chanc
born
homozyg
sicklecel
gene
associ
dire
consequ
issu
made
even
complic
parent
decid
favor
test
preimplant
intervent
affect
children
fact
grandchildren
descend
extent
may
seem
evid
offspr
would
prefer
riski
birth
born
parent
die
reproduct
determin
highli
person
one
requir
individu
util
risk
prefer
point
remain
howev
choic
intervent
offer
heterozyg
advantag
current
gener
choic
favor
risk
sicklecel
anemia
malaria
futur
gener
best
case
descend
place
posit
requir
intervent
biotechnolog
firm
insur
market
perpetu
possibl
worrisom
problem
made
clear
differ
level
consum
demand
outlin
avail
financi
resourc
given
appar
neg
correl
sicklecel
gene
preval
avail
financi
resourc
becom
unmistak
intervent
demand
visitor
expatri
fundament
differ
demand
local
popul
demand
visitor
expatri
contribut
profit
market
suppli
demand
local
popul
need
sustain
life
without
resourc
left
want
similar
circumst
pose
hiv
aid
firstworld
patient
demand
palli
enabl
live
diseas
thirdworld
patient
need
vaccin
defeat
plagu
sinc
financi
resourc
biotechnolog
compani
matter
firstworld
victim
resid
thirdworld
resourc
direct
intervent
technolog
far
littl
money
invest
vaccin
put
sharpest
possibl
point
issu
biotechnolog
compani
incent
perpetu
malaria
firm
heavili
invest
intervent
offer
heterozyg
advantag
would
see
selfperpetu
market
evapor
gener
malaria
erad
wipe
malaria
wipe
sicklecel
well
without
malaria
heterozyg
advantag
would
gone
homozygot
normal
individu
would
enjoy
substanti
advantag
homozyg
sicklecel
individu
would
quickli
disappear
perfectli
clear
accus
particular
firm
fact
engag
abhorr
uneth
practic
mere
intend
point
financi
incent
exist
remind
us
compani
respons
consum
also
sharehold
reli
profit
deploy
resourc
establish
market
genet
intervent
give
rise
uniqu
ethic
concern
heterozyg
advantag
possibl
turn
practic
consider
matter
might
address
clear
discuss
far
interact
technolog
advanc
consum
demand
notsounusu
circumst
need
financi
resourc
unevenli
distribut
present
complex
ethic
question
made
complex
target
genet
intervent
heterozyg
advantag
possibl
ethic
standard
question
address
given
dramat
inequ
econom
polit
power
differ
principl
rawl
rawl
see
also
daniel
immedi
come
mind
strict
applic
strongli
egalitarian
concept
behind
veil
ignor
would
sure
provid
ration
distribut
insur
polici
protect
possibl
one
us
might
find
shoe
fight
malaria
without
signific
market
power
assum
anyth
close
equal
appli
valuat
human
life
hard
imagin
even
tradit
utilitarian
standard
could
fail
achiev
palat
level
distribut
justic
purpos
howev
weigh
standard
might
use
judg
rel
util
distribut
option
particular
norm
question
anoth
day
instead
offer
three
modest
propos
would
aid
decis
make
use
whatev
standard
increas
avail
inform
shift
demand
reduc
intern
barrier
trade
stimul
appropri
product
promot
match
suppli
demand
propos
motiv
illconceiv
market
intervent
market
capabl
achiev
effici
outcom
lack
market
intervent
market
fail
demonstr
gener
model
heterozyg
advantag
develop
articl
law
genet
statist
law
larg
number
conspir
allow
us
luxuri
accur
monitor
polymorph
popul
equilibria
long
fundament
inform
rel
advantag
certain
genet
trait
variou
effort
genet
intervent
would
obvious
impact
model
affect
abil
monitor
well
abil
accur
forecast
popul
dynam
address
concern
propos
legal
report
requir
would
includ
aggreg
data
variou
intervent
type
undertaken
compliment
basic
demograph
data
effort
howev
imperfect
would
allow
us
accur
track
evolut
preval
specif
gene
affect
popul
free
flow
inform
would
allow
econom
agent
make
ration
decis
regard
care
admittedli
difficult
inform
would
offer
possibl
endogen
extern
product
activ
biotechnolog
firm
second
decept
simpl
propos
would
address
failur
world
market
malaria
intervent
put
bounti
malaria
approach
would
similar
effort
gate
foundat
target
hivaid
would
chang
incent
market
firm
develop
treatment
elimin
malaria
would
enjoy
appropri
gain
focus
sole
treat
firstworld
ramif
would
watch
market
disappear
whether
bounti
offer
privat
coalit
intern
health
organ
collabor
govern
care
calibr
would
cours
paramount
goe
without
say
credibl
offer
would
also
crucial
third
like
ambiti
propos
would
seek
end
illconceiv
market
intervent
worldwid
agricultur
market
level
play
field
broader
sens
process
although
us
eu
negoti
wto
doha
round
discuss
put
suggest
tabl
open
agricultur
market
fact
industri
nation
remark
restrict
access
thirdworld
countri
firstworld
agricultur
market
especi
import
due
domin
role
agricultur
play
develop
economi
compound
problem
firstworld
often
dump
agricultur
good
produc
excess
due
domest
subsidi
thirdworld
market
disastr
effect
price
driven
low
thirdworld
produc
compet
tremend
variabl
amount
dump
make
almost
imposs
predict
price
henc
plan
much
crop
plant
firstworld
govern
marketdistort
domest
subsidi
trade
barrier
thirdworld
product
deliber
make
imposs
countri
escap
poverti
firstworld
instead
chose
open
domest
market
agricultur
product
thirdworld
ceas
subsid
domest
product
virtuou
cycl
may
becom
selfreinforc
grow
economi
would
allow
greater
invest
public
privat
health
patient
thirdworld
countri
would
abl
afford
treatment
hitherto
reserv
visitor
expatri
prosper
countri
would
help
erad
malaria
would
provid
stabl
labor
forc
reduc
drain
chronic
sick
limit
resourc
poor
nation
almost
footnot
would
cours
make
genet
intervent
deal
irrelev
malaria
becam
extinct
would
advantag
sicklecel
allel
henc
time
natur
select
genet
drift
would
ensur
gradual
extinct
mutat
lie
within
power
becom
duti
work
direct
brook
p
articl
endeavor
care
consid
direct
might
target
firstworld
market
power
genet
intervent
regard
particular
allel
exhibit
heterozyg
advantag
circumst
rel
uncommon
wellknown
instanc
eg
sicklecel
allel
malaria
cystic
fibrosi
allel
cholera
dramat
affect
morbid
mortal
signific
portion
popul
emerg
market
genet
intervent
complex
particularli
sever
need
align
financi
resourc
consequ
dire
comment
call
higher
standard
privat
invest
biotechnolog
macdonald
remain
propon
free
market
function
effici
particular
circumst
would
hard
us
agre
fact
addit
call
legal
report
requir
eas
flow
relev
market
inform
call
new
market
intervent
one
instanc
elimin
market
intervent
anoth
place
bounti
head
would
address
real
need
thirdworld
popul
lack
financi
resourc
motiv
vaccin
research
develop
primarili
conduct
firstworld
laboratori
howev
comprehens
selfperpetu
propos
call
end
marketdistort
domest
agricultur
subsidi
trade
barrier
thirdworld
agricultur
product
way
thirdworld
countri
hope
build
effect
economi
stabl
market
selfsuffici
address
demand
public
health
relat
product
servic
larg
take
grant
end
becom
ethic
question
citizen
industri
countri
support
subsidi
domest
market
put
burden
us
